Monday, March 17, 2025 | 11:58 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

AstraZeneca and Pfizer Covid-19 vaccines to be combined in Oxford trial

The Astra and Pfizer vaccines will be given in different orders and with two dosing intervals, four and 12 weeks apart.

oxford, vaccine trials, coronavirus, covid-19
Premium

Bloomberg
The University of Oxford is set to begin a trial combining Covid-19 vaccines from AstraZeneca and Pfizer that could enable greater flexibility in the use of scarce supplies globally.
 
The university will begin recruiting 820 participants over 50 years of age across eight UK sites this week, according to a statement Thursday.
 
The Astra and Pfizer vaccines will be given in different orders and with two dosing intervals, four and 12 weeks apart.
 
The trial will allow researchers to see whether two shots of different vaccines produce better or worse results than two doses of the same

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in